Biotech · Public company · San Diego, CA, US

Aardvark Therapeutics, Inc.

Ticker AARD · SEC CIK 0001774857

Track this companyFree. Adds Aardvark Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials60 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialPHASE3 · TERMINATED · started Dec 20, 2024ClinicalTrials.gov NCT06828861 · fetched Nov 12, 2026
A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderPHASE2 · COMPLETED · started Aug 1, 2024ClinicalTrials.gov NCT06126653 · fetched Nov 12, 2026
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialPHASE3 · TERMINATED · started Jul 23, 2024ClinicalTrials.gov NCT07197034 · fetched Nov 12, 2026
A Study of Oral ARD-101 in Patients With Prader-Willi SyndromePHASE2 · COMPLETED · started May 27, 2022ClinicalTrials.gov NCT05153434 · fetched Nov 12, 2026
Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryPHASE2 · COMPLETED · started Mar 1, 2022ClinicalTrials.gov NCT05215847 · fetched Nov 12, 2026
Study to Evaluate ARD-101 in Adults With ObesityPHASE2 · COMPLETED · started Nov 15, 2021ClinicalTrials.gov NCT05121441 · fetched Nov 12, 2026